Arrowhead Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 20.22 M | $697.55 M | 4.12% | 14.55% |
| VANGUARD GROUP INC | 11/07/2025 | 16.04 M | $553.08 M | 3.29% | 11.53% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 10.90 M | $375.94 M | 2.83% | 7.84% |
| STATE STREET CORP | 11/14/2025 | 6.40 M | $220.65 M | 0.41% | 4.60% |
| FMR LLC | 11/13/2025 | 5.76 M | $198.66 M | 11.40% | 4.14% |
| SLATE PATH CAPITAL LP | 11/14/2025 | 4.98 M | $171.83 M | -4.78% | 3.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.13 M | $108.01 M | 5.12% | 2.25% |
| SIREN, L.L.C. | 11/13/2025 | 2.67 M | $92.08 M | 0.00% | 1.92% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.10 M | $72.41 M | 100.00% | 1.51% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 2.08 M | $71.80 M | 3,142.51% | 1.50% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.77 M | $61.18 M | -16.14% | 1.28% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 1.76 M | $60.68 M | -34.45% | 1.27% |
| MORGAN STANLEY | 11/14/2025 | 1.70 M | $58.73 M | -0.15% | 1.22% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 1.67 M | $57.62 M | 77.90% | 1.20% |
| MARSHALL WACE, LLP | 11/13/2025 | 1.44 M | $49.56 M | -33.36% | 1.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.35 M | $46.42 M | 14.96% | 0.97% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.31 M | $45.24 M | 3.11% | 0.94% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 1.05 M | $36.35 M | 133.32% | 0.76% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.00 M | $34.50 M | 34.04% | 0.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 993.00 K | $34.25 M | 100.00% | 0.71% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 973.57 K | $33.53 M | 1,853.19% | 0.70% |
| UBS GROUP AG | 11/13/2025 | 918.18 K | $31.67 M | -42.63% | 0.66% |
| WESTERN FINANCIAL CORP/CA | 10/21/2025 | 820.24 K | $28.29 M | 0.00% | 0.59% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 814.55 K | $28.09 M | -0.43% | 0.59% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 792.97 K | $27.35 M | 100.00% | 0.57% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 780.13 K | $26.91 M | 25.20% | 0.56% |
| JPMORGAN CHASE & CO | 11/26/2025 | 775.72 K | $26.75 M | 90.29% | 0.56% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 760.69 K | $26.24 M | 21.81% | 0.55% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 543.92 K | $18.76 M | 12.83% | 0.39% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/06/2025 | 539.34 K | $18.60 M | 25.90% | 0.39% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 534.10 K | $18.42 M | 620.78% | 0.38% |
| ABRDN PLC | 11/07/2025 | 520.64 K | $17.96 M | -45.78% | 0.37% |
| INVESCO LTD. | 11/13/2025 | 502.89 K | $17.34 M | -34.06% | 0.36% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 474.46 K | $16.36 M | 29.38% | 0.34% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/04/2025 | 473.95 K | $16.35 M | -22.58% | 0.34% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 402.66 K | $13.89 M | 100.00% | 0.29% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/13/2025 | 391.16 K | $13.49 M | 2.70% | 0.28% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 386.37 K | $13.33 M | -5.15% | 0.28% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 380.63 K | $13.13 M | 1,388.62% | 0.27% |
| NORDEA INVESTMENT MANAGEMENT AB | 10/27/2025 | 372.28 K | $12.66 M | 74.50% | 0.27% |
| RHUMBLINE ADVISERS | 11/06/2025 | 371.11 K | $12.80 M | 3.09% | 0.27% |
| BARCLAYS PLC | 11/12/2025 | 350.24 K | $12.08 M | -14.49% | 0.25% |
| CITADEL ADVISORS LLC | 11/14/2025 | 317.61 K | $10.95 M | 410.26% | 0.23% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2025 | 306.83 K | $10.58 M | 100.00% | 0.22% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 291.02 K | $9.84 M | 4.94% | 0.21% |
| NUVEEN, LLC | 11/12/2025 | 278.34 K | $9.60 M | -10.32% | 0.20% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 274.16 K | $9.46 M | 2.67% | 0.20% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 11/14/2025 | 272.97 K | $9.41 M | -2.57% | 0.20% |
| JOHNSON & JOHNSON | 11/13/2025 | 247.60 K | $8.54 M | 0.00% | 0.18% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 246.07 K | $8.49 M | 4.51% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arrowhead Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 433 institutional investors and hedge funds held shares of Arrowhead Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 20.22 M
VANGUARD GROUP INC: 16.04 M
Avoro Capital Advisors LLC: 10.9 M
STATE STREET CORP: 6.4 M
FMR LLC: 5.76 M
Slate Path Capital LP: 4.98 M
79.82% of Arrowhead Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 150.74 M shares in the last 24 months. This purchase volume represents approximately $5.44 B in transactions.